3Indexed trials
drug · Product Intelligence
Oxcarbazepine
Pipeline Intelligence
Oxcarbazepine: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT00275912Novartis · epilepsyPHASE4
NCT00467753University of Medicine and Dentistry of New Jersey · autismNA
NCT01891890Emory University · epilepsyPHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALOXCARBAZEPINE · 2025-04-30
FDA_APPROVALOXCARBAZEPINE · 2024-11-22
FDA_APPROVALOXCARBAZEPINE · 2023-10-20
FDA_APPROVALOXCARBAZEPINE · 2023-03-18
FDA_APPROVALOXCARBAZEPINE · 2022-11-04
FDA_APPROVALOXCARBAZEPINE · 2012-10-03
FDA_APPROVALOXCARBAZEPINE · 2012-09-17
FDA_APPROVALOXCARBAZEPINE · 2010-01-25
FDA_APPROVALOXCARBAZEPINE · 2007-12-11
FDA_APPROVALTRILEPTAL · 2000-01-14
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.